Delays in melanoma presentation during the COVID-19 pandemic: A nationwide multi-institutional cohort study.

Autor: Trepanowski N; Boston University School of Medicine, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Chang MS; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Zhou G; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Ahmad M; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut., Berry EG; Department of Dermatology, Oregon Health & Science University, Portland, Oregon., Bui K; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Butler WH; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Chu EY; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Curiel-Lewandrowski C; Division of Dermatology, The University of Arizona College of Medicine, Tucson, Arizona; The University of Arizona Cancer Center, Tucson, Arizona., Dellalana LE; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee., Ellis DL; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Dermatology, Nashville VA Medical Centers, Nashville, Tennessee., Freeman SC; Department of Dermatology, Oregon Health & Science University, Portland, Oregon., Gorrepati PL; University of Iowa Carver College of Medicine, Iowa City, Iowa., Grossman D; Department of Dermatology and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah., Gyurdzhyan S; Stanford University School of Medicine, Stanford, California., Kanetsky PA; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., King ALO; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut., Kolla AM; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York., Lian CG; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Lin JY; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Liu V; Departments of Dermatology and Pathology, University of Iowa Hospitals & Clinics, Iowa City, Iowa., Lowenthal A; Department of Dermatology and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah., McCoy KN; University of Virginia, Charlottesville, Virginia., Munjal A; University of Iowa Carver College of Medicine, Iowa City, Iowa., Myrdal CN; Division of Dermatology, The University of Arizona College of Medicine, Tucson, Arizona., Perkins S; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut., Powers JG; Department of Dermatology, University of Iowa Hospitals & Clinics, Iowa City, Iowa., Rauck C; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Smart TC; Department of Dermatology and Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah., Stein JA; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York., Venna S; University of Virginia School of Medicine, Charlottesville, Virginia; Inova Melanoma and Skin Cancer Center, Inova Schar Cancer Institute, Fairfax, Virginia., Walsh ME; Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa., Wang JY; Department of Dermatology/Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Palo Alto, California., Leachman SA; Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute at Oregon Health & Science University, Portland, Oregon., Swetter SM; Department of Dermatology/Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Palo Alto, California; Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California., Hartman RI; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, VA Integrated Service Network (VISN-1), Jamaica Plain, Massachusetts. Electronic address: rhartman@bwh.harvard.edu.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Nov; Vol. 87 (5), pp. 1217-1219. Date of Electronic Publication: 2022 Jun 20.

Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccination.

Autor: Myrdal CN; Division of Dermatology, The University of Arizona College of Medicine Tucson, Tucson, Arizona, USA., Culpepper KS; Division of Dermatology, The University of Arizona College of Medicine Tucson, Tucson, Arizona, USA.; Dermpath Diagnostics, Quest Diagnostics, Tucson, Arizona, USA., Leyo DuPont S; Oasis Dermatology, Green Valley, Arizona, USA.

Publikováno v: Dermatologic therapy [Dermatol Ther] 2021 Nov; Vol. 34 (6), pp. e15173. Date of Electronic Publication: 2021 Nov 06.

Coalescing plaques on the face, trunk, and upper extremities.

Autor: Myrdal CN; Division of Dermatology, The University of Arizona College of Medicine Tucson, Tucson, Arizona., Mesgarzadeh S; Division of Dermatology, The University of Arizona College of Medicine Tucson, Tucson, Arizona., Loh TY; Division of Dermatology, The University of Arizona College of Medicine Tucson, Tucson, Arizona., Culpepper KS; Dermpath Diagnostics, Quest Diagnostics, Tucson, Arizona., Curiel-Lewandrowski C; Division of Dermatology, The University of Arizona College of Medicine Tucson, Tucson, Arizona.

Publikováno v: JAAD case reports [JAAD Case Rep] 2021 Aug 23; Vol. 16, pp. 158-160. Date of Electronic Publication: 2021 Aug 23 (Print Publication: 2021).

Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy.

Autor: Myrdal CN; University of Arizona College of Medicine, Tucson, AZ, USA., Sundararajan S; Hematology and Oncology, Texas Oncology, Houston, TX, USA.

Publikováno v: Case reports in oncological medicine [Case Rep Oncol Med] 2020 Jun 25; Vol. 2020, pp. 4392562. Date of Electronic Publication: 2020 Jun 25 (Print Publication: 2020).

Comparison of knowledge, perception and attitudes of concussion in previously concussed versus non-concussed youth soccer players.

Autor: Myrdal CN; a College of Medicine , The University of Arizona , Tucson , AZ , USA., Huang S; b Departments of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health , The University of Arizona , Tucson , AZ , USA., Beach HN; c Department of Family and Community Medicine , The University of Arizona , Tucson , AZ , USA., Waterbrook AL; d Department of Emergency Medicine , The University of Arizona , Tucson , AZ , USA.

Publikováno v: The Physician and sportsmedicine [Phys Sportsmed] 2017 Sep; Vol. 45 (3), pp. 286-292. Date of Electronic Publication: 2017 Jun 30.